Odyssey Therapeutics, Inc.(ODTX)
Health Care
Biotechnology
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | COULTER JAMES G Other | Purchase | +1,388,889 | +60.35%3,690,146 | $18.00 | $25,000,002 | View SEC filing | |
| 2026-05-12 | Dimension Capital II, L.P. Director | Purchase | +1,111,111 | +50.00%3,333,516 | $18.00 | $19,999,998 | View SEC filing | |
| 2026-05-11 | George Simeon 10% Owner | Mixed | +553,775 | +19.32%3,420,548 | $18.00 | $10,032,030 | View SEC filing | |
| 2026-05-11 | LEIDEN JEFFREY M Director | Purchase | +5,000 | +1.68%301,842 | $20.00 | $100,000 | View SEC filing | |
| 2026-05-11 | Haas Jason Chief Financial Officer | Purchase | +1,000 | +1.62%62,908 | $20.00 | $20,000 | View SEC filing | |
| 2026-05-11 | Li Nan (LN) Director | Purchase | +1,111,111 | +50.00%3,333,516 | $18.00 | $19,999,998 | View SEC filing | |
| 2026-05-11 | Chu Shelley Director | Purchase | +11,111 | +100.00%11,111 | $18.00 | $199,998 | View SEC filing |
1-7 of 7